Handelsbanken Fonder’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,158
Closed -$223K 1638
2023
Q1
$223K Hold
6,158
﹤0.01% 1421
2022
Q4
$244K Hold
6,158
﹤0.01% 1351
2022
Q3
$287K Hold
6,158
﹤0.01% 1273
2022
Q2
$270K Hold
6,158
﹤0.01% 1385
2022
Q1
$445K Hold
6,158
﹤0.01% 1287
2021
Q4
$499K Hold
6,158
﹤0.01% 1343
2021
Q3
$717K Hold
6,158
﹤0.01% 1107
2021
Q2
$1.02M Buy
6,158
+300
+5% +$46.8K 0.01% 910
2021
Q1
$817K Sell
5,858
-1,700
-22% -$277K ﹤0.01% 933
2020
Q4
$1.31M Hold
7,558
0.01% 720
2020
Q3
$1.05M Buy
7,558
+2,800
+59% +$374K 0.01% 709
2020
Q2
$568K Buy
+4,758
New +$564K ﹤0.01% 909

Other funds holding NVRO

Handelsbanken Fonder's NVRO Position: Q2 2023 in Review

Handelsbanken Fonder sold out of NEVRO CORP. (NVRO) in Q2 2023, closing a stake of 6,158 shares — an estimated $223K sold.

Handelsbanken Fonder first reported a position in NVRO in Q2 2020 and held it in 12 quarters. The position peaked at $1.31M in Q4 2020. 155 funds tracked by Wall St. Rank hold NVRO as of Q2 2023.

  • Handelsbanken Fonder reported no remaining NEVRO CORP. position as of Q2 2023 after selling out during the quarter.
  • Handelsbanken Fonder sold 6,158 NEVRO CORP. shares in Q2 2023, an estimated $223K.
  • Handelsbanken Fonder first reported a position in NEVRO CORP. in Q2 2020 and held it in 12 quarters.
  • Handelsbanken Fonder's NEVRO CORP. position peaked at $1.31M in Q4 2020.
  • 155 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.